ZI
ABBV icon

ZEGA Investments’s AbbVie ABBV Stock Holding History

ZEGA Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.42M Sell
25,513
-1,306
-5% -$281K 0.66% 26
2026
Q1 		$5.83M Buy
26,819
+44
+0.2% +$9.76K 0.66% 25
2025
Q4 		$6.12M Buy
26,775
+1,255
+5% +$286K 0.72% 27
2025
Q3 		$5.91M Buy
25,520
+11,161
+78% +$2.27M 0.79% 23
2025
Q2 		$2.67M Sell
14,359
-1,478
-9% -$275K 0.36% 40
2025
Q1 		$3.32M Buy
15,837
+4,152
+36% +$807K 0.51% 30
2024
Q4 		$1.99M Buy
+11,685
New +$2.15M 0.5% 34

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ZEGA Investments's ABBV Position: Q2 2026 in Review

ZEGA Investments reduced its AbbVie (ABBV) stake by 4.9% in Q2 2026, selling an estimated $281K and leaving 25,513 shares worth $6.42M. The position accounts for 0.66% of the portfolio, ranked #26.

ZEGA Investments first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • ZEGA Investments held 25,513 shares of AbbVie worth $6.42M as of Q2 2026.
  • ZEGA Investments sold 1,306 AbbVie shares in Q2 2026, an estimated $281K.
  • AbbVie made up 0.66% of ZEGA Investments's portfolio in Q2 2026, its #26 holding.
  • ZEGA Investments first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ZEGA Investments's 13F filing for Q2 2026, filed 31 Jul 2026.